Sign in
CompletedNo phase

Object Assessment of Improvement in Non-Specific Symptoms After Parathyroidectomy for Primary Hyperparathyroidism

Key facts

Who runs it
The Cleveland Clinic
Where
Cleveland, United StatesSee the site
Trial code
Status
Completed
People taking part
45 people enrolled
Started
19 Jul 2022
Ended
29 Jun 2024
Type of study
Observational, 2 groups
Treatments tested
  • Activity Tracker (Fitbit)
  • HbA1C
  • The PROMPT Questionnaire
Record updated
6 August 2024

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Study group: Consecutive patients older than 18 years old who will undergo PTX for PHPT. The indications and need for surgery will be independent from the research team
  • Control group: Consecutive patients older than 18 years old who will undergo thyroidectomy for multinodular goiter (MNG). The indications and need for surgery will be independent from the research team

Who cannot take part

  • Sleep apnea and other sleep disturbances undergoing concurrent treatment
  • Established diagnosis of thyroid cancer or Graves' disease
  • Musculoskeletal or neurologic disorders that affect the patient's activity level
  • Cardiac arrhythmias that would interfere with the wearable electronic device measurement
  • Patients who are included but have evidence of recurrent or persistent PHPT based on six-month laboratory workup will be excluded from the final analysis (<5% expected)4
  • Patients with recurrent or persistent PHPT will not be included

Where in United States

  • The Cleveland Clinic FoundationCleveland, United States

About the trial

What the trial wants to find out

Wearable electronic devices are becoming more prevalent in daily life, as they offer real time information on physiological parameters such as heart rate, activity level, oxygenation, and sleep patterns for their users. These wearable electronic devices are easy to install and offer no major risk or discomfort to the user. Implementation of these technologies into medicine has exponentially grown in the past decade with supporting evidence for their use in cardiovascular disease and sleep medicine. The investigators believe that these devices will be able to capture the changes associated with improvement in non-specific symptoms that have not been previously demonstrated.

The 2 groups in the trial

  • 40 patients with primary hyperparathyroidism

    patients undergoing parathyroidectomy for primary hyperparathyroidism

    Treatment: Activity Tracker (Fitbit), HbA1C, and The PROMPT Questionnaire

  • 40 patients with multinodular goiters

    patients undergoing thyroidectomy for multinodular goiter

    Treatment: Activity Tracker (Fitbit), HbA1C, and The PROMPT Questionnaire

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
6 August 2024